Emily Fisher Landau Professor of Neurology
PI, Clinical Data Animation Center (CDAC)
Harvard Medical School
Beth Israel Deaconess Medical Center (BIDMC)
Office: BIDMC, 444 Kirstein, 330 Brookline Ave, Boston, MA 02215, USA
Affiliations | Bio | CV | Research funding | Disclosures | Quote collection | Blog-Alek | Blog-AGT
BIDMC Neurology Department
MGH McCance Center for Brain Health, Director of Data Science
Beacon Biosignals, co-founder
MIT, Research Affiliate Faculty
Harvard-MIT Health Sciences & Technology (HST) Program, Faculty
Harvard Medical School
Broad Institute, Research Affiliate Faculty
M. Brandon Westover, MD, PhD is the Emily Fisher Landau Professor of Neurology at Harvard Medical School. He earned his PhD in Physics working in the field of information theory. He is a board-certified Neurologist and Clinical Neurophysiologist practicing at Beth Israel Deaconess Medical Center, where he directs the Critical Care EEG Monitoring Service. His research group, the Clinical Data Animation Center, develops machine learning approaches to improve medical care for patients with neurological problems including anoxic brain injury, seizures, cerebral ischemia, delirium, and sleep disorders. He is a co-producer of EEGTalk, author of Pocket Neurology and Atlas of Intensive Care Quantitative EEG, and co-founder of Beacon Biosignals.
CDAC research is funded by the following grants:
RF1NS120947 Establishing a Brain Health Index from the Sleep Electroencephalogram
R01AG073410 Comparative Safety of Seizure Prophylaxis within the Medicare Program.
R01HL161253 Data-Driven Sleep Biomarkers of Brain Health, Heart Health, and Mortality (“CAISR”).
R01NS126282 Prospective Validation of Neurophysiologic Outcome Prediction in Acute Brain Injury (“ABIEE”).
R01AG073598 Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer’s Disease and Neurovascular Pathology, Delirium risk and Inattention.
R01NS131347 Comparative effectiveness of EEG-guided anti-seizure treatment in acute brain injury (“PKPD”)
R01NS130119 Late-onset unexplained epilepsy as a risk factor for dementia (“ELUCID”)
AWS HEI grant
Past CDAC funding:
R01NS102190 Investigation of Sleep in the Intensive Care Unit (ICU-SLEEP).
R01NS102574 Multimodal network connectivity architecture (MOCA) of the brain and its role in the recovery of consciousness in comatose cardiac arrest patients.
R01NS107291 Big Data and Deep Learning for the Interictal-Ictal-Injury Continuum.
RF1AG064312 Integrated motor activity biomarker for the risk of Alzheimer’s dementia (ADVANCE).
NSF 2014431 Collaborative Research: DeepSense: Interpretable Deep Learning for Zero-effort Phenotype Sensing and Its Application to Sleep Medicine.
Short version: Dr. Westover’s laboratory is supported by grants from the NIH (R01AG073410, R01HL161253, R01NS126282, R01AG073598, R01NS131347, R01NS130119, and AWS. Back to Top
Disclosures / COI statement: Dr. Westover is a co-founder, serves as a scientific advisor and consultant to, and has a personal equity interest in Beacon Biosignals. If you have concerns about Dr. Westover’s relationship with Beacon Biosignals, you can contact a Co-Chair of the BIDMC Conflict of Interest Committee, BIDMC Department of Integrity and Compliance, or the BIDMC Speak Up Hotline. Dr. Westover receives royalties for authoring Pocket Neurology from Wolters Kluwer and Atlas of Intensive Care Quantitative EEG by Demos Medical.